Curated News
By: NewsRamp Editorial Staff
September 29, 2025
FAVO Capital Appoints Healthcare Leader Dr. Wael Barsoum to Board
TLDR
- FAVO Capital gains strategic advantage by appointing healthcare innovation leader Dr. Wael Barsoum to guide its next growth phase with enhanced governance expertise.
- FAVO Capital appointed Dr. Wael Barsoum as an independent director, adding decades of healthcare leadership experience to strengthen board oversight and organizational growth strategies.
- This appointment strengthens FAVO Capital's ability to support small businesses through alternative funding, contributing to economic growth and sustainable community development.
- FAVO Capital brings in a former Cleveland Clinic CEO to its board, blending healthcare innovation expertise with financial services for unique strategic direction.
Impact - Why it Matters
This appointment signals FAVO Capital's potential strategic expansion into healthcare innovation and investment, leveraging Barsoum's extensive experience in healthcare leadership and transformation. For investors and the business community, this move suggests FAVO may be positioning itself to capitalize on opportunities in the rapidly evolving healthcare sector, potentially diversifying its revenue streams beyond traditional financial services and real estate. Given Barsoum's background at Cleveland Clinic Florida and Healthcare Outcomes Performance Company, his expertise could help FAVO navigate healthcare investments, partnerships, or funding solutions for medical businesses. This strategic board addition comes at a time when healthcare innovation and financing are increasingly critical, potentially opening new growth avenues for the company while bringing healthcare sector credibility to FAVO's financial services platform.
Summary
FAVO Capital (OTC: FAVO), a diversified financial company operating in financial services and real estate, has announced a significant board appointment that signals strategic expansion into healthcare innovation. The company revealed that Dr. Wael Barsoum, former president and CEO of Cleveland Clinic Florida and current president and chief transformation officer at Healthcare Outcomes Performance Company, has joined FAVO Capital's board of directors as an independent director. This appointment brings decades of healthcare leadership experience to the financial services firm, with Barsoum's background in healthcare innovation, governance, and organizational growth positioning FAVO for potential new ventures in the healthcare sector. Shaun Quin, president of FAVO Capital, emphasized that Barsoum's appointment reflects the company's commitment to building a board with the independence, depth, and experience needed to guide FAVO's next chapter of growth.
FAVO Capital operates across two primary segments: financial services and selective real assets. Through its financial services division, the company provides alternative, revenue-based funding solutions to small and mid-sized businesses across the United States, having supported more than 10,000 businesses through the purchase of future receipts since its inception. Complementing its lending platform, FAVO is building a portfolio of selective real assets that strengthen its balance sheet and broaden its collateral base. Headquartered in Fort Lauderdale, Florida, with operations in Florida, New York, and the Dominican Republic, FAVO Capital maintains a commitment to financial transparency, sustainable growth, and long-term value creation for its shareholders. The company's news is distributed through NetworkNewsWire, which provides comprehensive financial news distribution services as part of the Dynamic Brand Portfolio through IBN, offering enhanced press release services and broad market reach.
Source Statement
This curated news summary relied on content disributed by InvestorBrandNetwork (IBN). Read the original source here, FAVO Capital Appoints Healthcare Leader Dr. Wael Barsoum to Board
